drugset / Trial / NCT06143631
Prescription of Letrozole for Uterine Myoma
Phase 4
Recruiting
140 enrolled
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
Timeline
- Start
- 2024-07-24
- Primary completion
- 2028-09-11
- Completion
- 2028-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |